Comparative Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin‐Norepinephrine Reuptake Inhibitors in Older Adults: A Network Meta‐Analysis

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 5, 2015-05 ,pp. : 1002-1009

John Wiley & Sons Inc

Access to resources Recommend Favorite

Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors

By Signorovitch James   Ramakrishnan Karthik   Ben-Hamadi Rym   Yu Andrew P.   Wu Eric Q.   Dworak Heather   Erder M. Haim  

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1089-1096

Informa Healthcare

Access to resources Recommend Favorite

Differences in compliance patterns across the selective serotonin reuptake inhibitors (SSRIs)

By Keene Matthew S.   Eaddy Michael T.   Mauch Robert P.   Regan Timothy S.   Shah Manan   Chiao Evelyn  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1651-1658

Informa Healthcare

Access to resources Recommend Favorite

The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors

By Wang Junling   White-Means Shelley I.   Hufstader Meghan A.   Walker Genene D.  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 853-863

Informa Healthcare

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors and Suicide: Is the Evidence, as with Beauty, in the Eye of the Beholder?

By  

Psychotherapy and Psychosomatics, Vol. 72, Iss. 6, 2003-10 ,pp. : 293-299

Karger

Access to resources Recommend Favorite